Skip to main content
Image of reading glasses on top of books
Oct 2022
Lesley's Story

Since being diagnosed with glaucoma, I have been using several types of eye drops for 42 years.

Click this to read more.
Image of Dr Owen Siggs
Oct 2022
Glaucoma Australia to Fund Promising Genomic Risk Stratification Research

To commemorate 'World Sight Day', Glaucoma Australia and its Patron, the Governor-General of Australia, His Excellency the Honourable David Hurley, are pleased to announce the 2022 recipient of the charity’s ‘Quinlivan’ Research Grants Program. 

Click this to read more.
Image of Ty Nuygen
Oct 2022
Eye Drop Compliance Vital in Curbing Rapid Vision Loss for Melbourne Mum

To celebrate World Sight Day and this year’s theme of #loveyoureyes, the Royal Victorian Eye and Ear Hospital has shared the story of one of their glaucoma patients with the hopes of raising awareness about the importance of eye-drop treatment adherence. 

Click this to read more.
Image of the iDose TR
Sep 2022
A Promising Alternative to Daily Eye drops? Positive Outcomes for Phase 3 ...

Glaukos Corporation has announced positive data for Phase 3 trials of iDose TR. 

Click this to read more.
An image of reading glasses and a reading chart
Sep 2022
Christine's Story

My sister, who is four years older than I am, went to her local hospital, the Queen Elizabeth in Glasgow, Scotland.

Click this to read more.
Image of a woman with African heritage smiling
Sep 2022
New Research Study Reveals Ethnicity Increases Glaucoma Risk

A recent study from the New York Eye and Ear Infirmary of Mount Sinai showed that being of African heritage increased the risk of vision loss due to glaucoma. 

Click this to read more.
Inage of woman suffering from a migraine with her hands on her temples
Sep 2022
The Clinical Impact of Migraine for the Management of Glaucoma Patients

An invited review of the available literature on migraine and its impact on testing for glaucoma was published in 2016. 

Click this to read more.
Lei
Sep 2022
Lei's Story

I had suffered migraines for years on and off but then started feeling like my eyes were wanting to explode, like there was a heaviness to them and a lot of pressure. 

Click this to read more.
Dr Ondrejka (right) performs a canaloplasty procedure with the new iTrack Advance device. During the withdrawal of the microcatheter, the scrub nurse (left) titrates the ViscoInjector viscoelastic delivery device to deliver a custom volume of OVD, based on the patient’s pathology.
Aug 2022
iTrack Advance CATALYST Study Launched

The first patient has been enrolled in a prospective, randomised, multicentre study to investigate canaloplasty with the new iTrack Advance CATALYST Study.

Click this to read more.